Ophthalmologist

M&A Snapshot

  • Deal volume in 1st half of 2023 was down from 2022, which was a record year.
  • Multiples are trending upwards, reaching 2021 values.
  • Non-essential specialties, such as plastics, dermatology and medical devices are selling for higher multiples.
  • Dermatology experienced one of the highest increases in multiples since 2020.
  • The higher the EBITDA the higher the multiple.